NCT00205465View on ClinicalTrials.gov

Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

September 30, 2005

Conditions
Psoriasis
Interventions
DRUG

VX-765

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT00205465 - Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765 | Biotech Hunter | Biotech Hunter